This is a study protocol describing the methodology for developing a core outcome set (COS) for clinical trials of Food for Special Medical Purposes (FSMP) designed for type 2 diabetes mellitus.
Trials · 7 authors, 5 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This is a study protocol describing the methodology for developing a core outcome set (COS) for clinical trials of Food for Special Medical Purposes (FSMP) designed for type 2 diabetes mellitus.
This is a study protocol describing the methodology for developing a core outcome set (COS) for clinical trials of Food for Special Medical Purposes (FSMP) designed for type 2 diabetes mellitus. Limitations noted include the potential for limited international applicability, as the study is not international, and the challenge of achieving consensus among diverse stakeholder groups. The implications are that a successful COS could standardize outcome measurement in FSMP trials for T2DM, improving communication and efficiency in research and regulation.